P-glycoprotein as a therapeutic target: good news
Author:
- Aa ShtilASAa Shtil
- 1 October 2002
- journal article
- Published by Springer Nature in Leukemia
- Vol. 16 (10) , 2169-2170
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The cyclosporin PSC 833 increases survival and delays engraftment of human multidrug-resistant leukemia cells in xenotransplanted NOD-SCID miceLeukemia, 2002
- Signaling pathways activated by daunorubicinBlood, 2001
- P-glycoprotein Does Not Protect Cells against Cytolysis Induced by Pore-forming ProteinsJournal of Biological Chemistry, 2001
- Targeting Ceramide Metabolism--a Strategy for Overcoming Drug ResistanceJNCI: Journal of the National Cancer Institute, 2001
- Signal Transduction Pathways and Transcriptional Mechanisms as Targets for Prevention of Emergence of Multidrug Resistance in Human Cancer CellsCurrent Drug Targets, 2001
- Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthaseBritish Journal of Cancer, 1999
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates PhosphatidylcholineCell, 1996